Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-115148
Filing Date
2024-10-16
Accepted
2024-10-16 21:22:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3252
  Complete submission text file 0000950170-24-115148.txt   4686
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Subject) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40971 | Film No.: 241375736
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT STE 200 SAN DIEGO CA 92121
Business Address
Plavsic Mark (Reporting) CIK: 0001868719 (see all company filings)

Type: 144